Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Sensant Corporation was a pioneer in the field of medical imaging, specifically focusing on the development of Capacitive Micromachined Ultrasonic Transducers (CMUT). Founded as a spin-off from Stanford University, the company utilized micro-electro-mechanical systems (MEMS) technology to create silicon-based ultrasound transducers. These devices offered significant advantages over traditional piezoelectric transducers, including improved image resolution, wider bandwidth, and the ability to be integrated directly with CMOS electronics. Sensant's technology enabled the development of advanced 2D and 3D ultrasound probes for diagnostic applications. In 2005, the company was acquired by Siemens Medical Solutions, which integrated Sensant's CMUT technology into its Acuson ultrasound product line.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Sensant.